tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tyler Bussian, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst Tyler Bussian, currently employed at BROOKLINE,
Tyler Bussian’s has documented 8 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on CRVO, CervoMed at 10-Jun-2026.
Analyst best performing recommendations are on CRVO (CERVOMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2025
$25
$21.78 (676.40%)
$25
Buy Since 15-Feb-2024
$18
$14.78 (459.01%)
$27
2 months ago
(10-Aug-2026)
0/5 (0%)
$15.14 (529.37%)
Buy Since 17-Mar-2025
$15
$11.78 (365.84%)
$15
4 months ago
(10-Jun-2026)
0/3 (0%)
$12.75 (566.67%)
Buy Since 11-Aug-2025
$31
$27.51 (788.25%)
$31
5 months 18 days ago
(22-Apr-2026)
0/5 (0%)
$27.06 (686.80%)
Buy Since 05-Dec-2024
$11
$7.51 (215.19%)
$16
6 months 22 days ago
(18-Mar-2026)
0/4 (0%)
$6.76 (159.43%)
Which stock is Tyler Bussian most bullish on?
What Year was the first public recommendation made by Tyler Bussian?
